Cargando…

Tyrosinemia type 1 and ADHD like symptoms similarity or comorbidity about a case

INTRODUCTION: Many metabolic diseases influence brain function and are associated with psychiatric symptoms and neuropsychiatric disorders (including autism-spectrum disorders, ADHD and psychotic disorders). Attention-deficit-/hyperactivity disorder (ADHD) is among the most common neurodevelopmental...

Descripción completa

Detalles Bibliográficos
Autores principales:	Belhadga, H., Elmaataoui, Z., Kisra, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434416/ http://dx.doi.org/10.1192/j.eurpsy.2023.1081

Ejemplares similares

Management of risperidone-induced hyperprolactinemia in children: a case report
por: Belhadga, H., et al.
Publicado: (2023)

The metabolic syndrom and the prescription of psychotropic drugs in children and adolescents: three clinical cases
por: Elmaataoui, Z., et al.
Publicado: (2023)

Isoniazid-induced acute psychotic episode in a child with lymph nodes tuberculosis: case report and literature review
por: Belhadga, H., et al.
Publicado: (2023)

The involvement of hyperhomocysteinemia in the development of characterized depressive disorder in children and adolescents
por: Elmaataoui, Z., et al.
Publicado: (2023)

Antipsychotics and spermatogenesis, which is the impact?: A review of literature
por: Belhadga, H., et al.
Publicado: (2023)

Association between autoimmune diseases and mental disorders in children and adolescents
por: Elmaataoui, Z., et al.
Publicado: (2023)

Maternal autoimmune diseases and mental disorders in children and adolescents
por: Elmaataoui, Z., et al.
Publicado: (2023)

Therapeutic update in the treatment of disruptive disorder with emotional dysregulation in children and adolescents : review of the literature
por: Belhadga, H., et al.
Publicado: (2023)

Case report: ADHD and prognosis in tyrosinemia type 1
por: Barone, Helene, et al.
Publicado: (2023)

Problematic video game use in adolescents and psychosocial functioning
por: Belabbes, I., et al.
Publicado: (2023)

Suicidal crisis in the adolescent: About 3 clinical cases
por: Belabbes, I., et al.
Publicado: (2023)

Borderline personality disorder in adolescents: Descriptive study about a series of cases
por: Belabbes, I., et al.
Publicado: (2023)

Comment on Pancreatitis in Type 1 Tyrosinemia
por: Rahmoune, Hakim, et al.
Publicado: (2017)

Management of comorbid schizophrenia with prolactinome (about a case)
por: Chamsi, F. Z., et al.
Publicado: (2023)

Hepatorenal tyrosinemia
por: KITAGAWA, Teruo
Publicado: (2012)

Tyrosinemia type III in an asymptomatic girl
por: Szymanska, Edyta, et al.
Publicado: (2015)

Treatment adherence in tyrosinemia type 1 patients
por: González-Lamuño, Domingo, et al.
Publicado: (2021)

Syndrome of hereditary tyrosinemia in mink
por: Christensen, K, et al.
Publicado: (1978)

Type 1 tyrosinemia in Finland: a nationwide study
por: Äärelä, Linnea, et al.
Publicado: (2020)

Comorbid adult adhd and bipolar affective disorder – assessment challenges
por: Pereira, I., et al.
Publicado: (2021)

ASD and ADHD Comorbidity: What Are We Talking About?
por: Hours, Camille, et al.
Publicado: (2022)

Is ADHD a sleep disorder? can adhd improve by treating the comorbid sleep disorder(S)? a research update
por: Kooij, J.J.S.
Publicado: (2021)

Treatment of early resistant schizophrenia: a case report
por: Benhammou, S., et al.
Publicado: (2023)

Cri du chat syndrome and autism spectrum disorder: a case report
por: Raissouni, M., et al.
Publicado: (2023)

A Case of Tyrosinemia Type III with Status Epilepticus and Mental Retardation
por: Najafi, Reza, et al.
Publicado: (2018)

TYROSINEMIA TYPE III: A CASE REPORT OF SIBLINGS AND LITERATURE REVIEW
por: Barroso, Fábio, et al.
Publicado: (2020)

Severe neurological crisis in adult patients with Tyrosinemia type 1
por: Dawson, Charlotte, et al.
Publicado: (2020)

Revisiting hereditary tyrosinemia Type 1—spectrum of radiological findings
por: Shaikh, Sana, et al.
Publicado: (2018)

Hereditary Tyrosinemia Type 1 in Jordan: A Retrospective Study
por: Megdadi, Noor A., et al.
Publicado: (2021)

Biomarkers of Micronutrients in Regular Follow-Up for Tyrosinemia Type 1 and Phenylketonuria Patients
por: van Vliet, Kimber, et al.
Publicado: (2019)

Neurocognitive outcome in tyrosinemia type 1 patients compared to healthy controls
por: van Ginkel, Willem G., et al.
Publicado: (2016)

Evolution of tyrosinemia type 1 disease in patients treated with nitisinone in Spain
por: Couce, María Luz, et al.
Publicado: (2019)

Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I
por: Daly, Anne, et al.
Publicado: (2021)

Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1
por: Li, Li, et al.
Publicado: (2017)

Clinical utility of nitisinone for the treatment of hereditary tyrosinemia type-1 (HT-1)
por: Das, Anibh Martin
Publicado: (2017)

Blood and Brain Biochemistry and Behaviour in NTBC and Dietary Treated Tyrosinemia Type 1 Mice
por: van Ginkel, Willem G., et al.
Publicado: (2019)

On the screening, diagnosis, and treatment of adolescent and adult ADHD patients with comorbid substance use: international guidelines
por: Crunelle, C. L.
Publicado: (2023)

Long-Term Outcomes and Practical Considerations in the Pharmacological Management of Tyrosinemia Type 1
por: van Ginkel, Willem G., et al.
Publicado: (2019)

Phenotype, genotype, and outcome of 25 Palestinian patients with hereditary tyrosinemia type 1
por: Dweikat, Imad, et al.
Publicado: (2021)

Therapeutic Targeting of Fumaryl Acetoacetate Hydrolase in Hereditary Tyrosinemia Type I
por: Gil-Martínez, Jon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q3cb8lflerfqrckplsbt78n3k4